All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Security
Security
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

Study: IV Lidocaine Infusion Offers Short-to-Medium Term Relief for Chronic Pain Patients

A study led by Abdelhady S.M. Ali of University Hospitals of Leicester NHS Trust found that intravenous lidocaine infusion provides short-to-medium term pain relief for chronic pain patients, with only mild side effects and high patient satisfaction. However, researchers caution that definitive conclusions about long-term efficacy cannot be drawn from this dataset alone.

Edited by Archita Rai6d ago1 min readenNews
Read on mdsc.pe

Key quotes

Patients with chronic pain who received an intravenous (IV) infusion of lidocaine reported relief from pain in the short-to-medium term, encountered only mild side effects, and reported high overall satisfaction with the treatment.
Although IV lidocaine 'may provide short- to medium-term analgesic benefit, definitive conclusions regarding sustained long-term efficacy cannot be drawn from this dataset alone,' the researchers reported.

From the article

An intravenous infusion of lidocaine in patients with chronic pain is associated with clinically meaningful relief from pain and mild side effects, a study finds.
Continue reading on mdsc.pe

You might also wanna read

Comments

Sign in to join the conversation.

No comments yet. Be the first.